MANA RBM's network of clinical researchers reported that research sites are eliminating onsite monitoring visits. If onsite monitoring visits are a Sponsor's main oversight approach, the solution to this critical problem is available now.
MANA RBM provides remote, automated risk-based monitoring (RBM) customized to a site's protocol. The company delivers its solution, customized to the areas of greatest concern, specific to a study. Subject review can begin within days.
"We recently published an example of this successful approach, adding remote Risk Based Monitoring to trials being conducted with traditional SDV," said Penny Manasco, M.D., CEO of MANA RBM. "Within days, we started remote subject review. Within 2 months, we identified critical errors that SDV did not find."
Here is the link to the head to head comparison:
http://www.appliedclinicaltrialsonline.com/comparing-risk-based-monitoring-and-remote-trial-management-vs-sdv
March 17, 2020
Topic Area: Press Release
Recent Posts
Healthcare Is the New Retail
How site selection strategies are shaping the future of medical real estate.
Bridgeway Behavioral Health Services Launches Campaign to Renovate Health Center
The $2 million capital campaign aims to renovate and expand the outpatient behavioral health center in Elizabeth, New Jersey.
Ground Broken for New North Dakota State Hospital
The 300,000-square-foot facility in Jamestown will provide 140 beds in a modern, trauma-informed care environment.
AI Usage for Healthcare Facilities
People in all industries are finding more use cases for artificial intelligence.
Ground Broken on Pelican Valley Senior Living Modernization Project
It is expected to reach completion in early-mid 2027.